Skip to main content

Table 2 Chemotherapy compliance and toxicity

From: Retrospective analyses of cisplatin-based doublet combination chemotherapy in patients with advanced gastric cancer

 

XP (n = 77)

SP (n = 97)

DP (n = 72)

FP (n = 37)

Chemotherapy courses

    

   Median

4

5

5

4

   Range

1-9

1-15

1-10

1-14

Reasons for discontinuation

    

   Progressive disease

28

41

49

21

   Toxicity

6

6

4

3

   Withdrawal

3

16

3

4

   Physician recommendation

34

29

14

9

   Unknown

6

5

2

0

Overall grade 3 or 4 toxicity

68

73

67

30

Treatment-related deaths

1

0

0

2